Distinguished in Multiple Sclerosis (MS)

Toshiyuki Takahashi

Fujieda, JP 
Distinguished in Multiple Sclerosis (MS)
Fujieda, JP 
OverviewLocationsClinical Research

Overview

Toshiyuki Takahashi practices in Fujieda, Japan. Mr. Takahashi is rated as a Distinguished expert by MediFind in the treatment of Multiple Sclerosis (MS). His top areas of expertise are Optic Neuritis, Transverse Myelitis, Neuromyelitis Optica, Laminectomy, and Vertebroplasty.

His clinical research consists of co-authoring 448 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 44 articles in the study of Multiple Sclerosis (MS).

Gender
Male

Locations

Fujieda, Japan
Other Locations
Yonezawa, 9921202, Japan
Shiba, 1080073, Japan
Sapporo, Japan
Sendai, Japan
Shimotsuke, Japan
Tokyo, Japan
Hakodate, 0408611, Japan
Head And Neck Surgery, 1-757, Asahimachi Dori, Chuo, 9518510, Japan
Minato, Japan
Miyakonojo, 8858567, Japan
Shizuoka, Japan
Hiroshima, Japan
Kanagawa, Japan
Ube, Japan
Japan
Tochigi, 3290412, Japan
Akita, Japan
Tohoku, Japan
Chiba, 2618502, Japan
Aomori, Japan
Minato, 1080073, Japan
Morioka, Japan
Kitakyushu, Japan
Koga, Japan
Yokote, Japan
Mihama, Japan
Obihiro, Japan
Kawasaki, Japan
Hongo, 1130033, Japan
Utsunomiya, Japan
Yamagata, Japan
Nagasaki, Japan
Yokohama, Japan
Ashikaga, Japan
Bunkyo, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Efficacy and Safety of Once-Weekly Tirzepatide in Participants With Obesity Disease: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-J)
Efficacy and Safety of Once-Weekly Tirzepatide in Participants With Obesity Disease: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-J)
Enrollment Status: Completed
Publish Date: July 16, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3

448 Total Publications

A Commentary on the Special Issues "Craniovertebral Junction (CVJ) Challenges".
A Commentary on the Special Issues "Craniovertebral Junction (CVJ) Challenges".
Journal: Neurospine
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Takahashi's expertise for a condition
ConditionClose
View All 18 Advanced Conditions
View All 92 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile